What is the catalog number for Amiodarone-d4 Hydrochloride?

The catalog number for Amiodarone-d4 Hydrochloride is CS-O-06401.

What sizes are available for Amiodarone-d4 Hydrochloride?

Amiodarone-d4 Hydrochloride is available in the following size(s): 1 Each.

Is Amiodarone-d4 Hydrochloride in stock?

Amiodarone-d4 Hydrochloride is currently made to order / not held in immediate stock. Contact us for lead time.

Where can I find the safety data sheet (SDS/MSDS) for Amiodarone-d4 Hydrochloride?

The safety data sheet for Amiodarone-d4 Hydrochloride is available here: https://msds_v1.clearsynth.com/msds.asp?catnumber=CS-O-06401.

Amiodarone-d4 Hydrochloride

Amiodarone-d4 Hydrochloride is listed under Stable Isotopes and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Amiodarone. The product is supplied by Clearsynth under CAT No. CS-O-06401. Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.

Product Specifications

Overview

Amiodarone is an antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascul

CAS Number

1216715-80-8

Synonyms

Amiodarone-d4 Hydrochloride

Molecular Formula

C 25 H 26 D 4 ClI 2 NO 3

Molecular Weight

685.80

Additionnal Information

Amiodarone-d4 Hydrochloride is supplied with detailed characterization data compliant with regulatory guideline. Amiodarone-d4 Hydrochloride can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Amiodarone.

Storage Conditions

Refer MSDS for complete information.

Applications Notes

Amiodarone is an antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascul